To access the video for non-CME credit, please visit https://nccrcg.org/knowledge-nugget-series/
NCC Knowledge Nugget Series: Glutaric Acidemia Type 1 ACT Sheet
Date of Release: June 10, 2024Expiration Date: June 10, 2026Credits offered: CMEEstimate time of completion: 15 minutes Course must be completed by the expiration date
Course Description:The ACMG ACT Sheets and Algorithms are a clinical decision support tool for non-genetics providers that describe the short term actions a health professional should follow in communicating with the family and determining the appropriate steps in the follow-up of the infant that has screened positive. To offer a more active and engaging educational opportunity to accompany the ACT Sheets, the National Coordinating Center for the Regional Genetics Networks (NCC) publishes the Knowledge Nugget Series. These quick sessions allow providers to review the existing ACT Sheets and provide a deep dive into a particular ACT Sheet through an animated video. The video in the series is the Knowledge Nugget: Glutaric Acidemia Type 1 ACT Sheet.Target Audience: Healthcare Providers, Public Health Professionals
Learning Objectives:
At the conclusion of this session, participants should be able to:1. Identify the purpose of the ACMG ACT Sheets.2. Describe how a newborn screening differs from a confirmatory test.3. List the next steps a provider should take once they receive an out-of-range newborn screening result for Glutaric Acidemia Type 1.NCC Funding AcknowledgementThis project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under Cooperative Agreement #UH9MC30770 from 6/2020-5/2024 for $800,000 per award year. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.
Contributor:Amy Gaviglio, MS, CGCLicensed Certified Genetic Counselor,Connetics ConsultingPlanning committee members:Joann Bodurtha, MD, MPH, FACMGMegan Lyon, MPHNancy Rose, MD, FACMG
Continuing Medical Education (CME AMA & CME Other)
Accreditation
The American College of Medical Genetics and Genomics is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation The American College of Medical Genetics and Genomics designates this enduring activity for a maximum of .25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Claiming your Educational CreditsThis activity consists of: View content, take a post-test, the test may be taken as often as necessary to achieve a passing score of 80% or better is required to receive credit. If you do not achieve a passing score, the program will identify which questions you answered incorrectly so that you can review the module and try again. Complete the evaluation form.Learner Data ConsentACMG Education reports learner data to respective agency boards and you will be asked for consent during the evaluation process. Your compliance with deadlines and completing evaluations are part of the process in meeting learner needs and ACMG’s education mission.
Accredited Continuing Education Financial DisclosureThe American College of Medical Genetics and Genomics (ACMG) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide Accredited Continuing Education (ACE) for physicians. ACMG is an organization committed to improvement of patient care and general health by the incorporation of genetics and genomics into clinical practice.ACMG has implemented the following procedures to ensure the independence of ACE activities from commercial influence/promotional bias, the Accreditation Council for Continuing Medical Education (ACCME) requires that providers (ACMG) must be able to demonstrate that: 1) everyone in a position to control the content of an ACE activity has disclosed all financial relationships that they have had in the past 24 months with ineligible* companies; 2) ACMG has implemented a mechanism to mitigate relevant financial relationships; and 3) all relevant financial relationships with ineligible companies are disclosed to the learners before the beginning of the educational activity. The learners must also be informed if no relevant financial relationships exist.*Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
ACMG Education PoliciesPlease review the policies below regarding the ACMG Education program• Financial Disclosures and Mitigation Procedure • ACMG Content Validation Policy• ACMG Content Branding PolicyAll of the relevant financial relationships listed for these individuals have been mitigated.